The AMP-activated protein kinase (AMPK) is the central component of a protein kinase cascade which plays an important role in the regulation of many different aspects of lipid metabolism [1, 2] . AMPK is activated 50-to 100-fold by phosphorylation by an upstream protein kinase, AMPK kinase (AMPKK) [3] . The key regulators of the AMPK cascade currently appear to be S'-AMP and ATP. AMP activates the system through no less than four mechanisms [4-61: (1) direct allosteric activation (up to 5-fold); (2) binding to AMPK, making it a better substrate for AMPKK; (3) binding to AMPK, making it a worse substrate for the inactivating phosphatase, protein phosphatase-2C; and (4) allosteric activation of AMPKK. High levels of ATP antagonize effects (1) and (3) of AMP [4, 6] , and also antagonize the effect of AMP on phosphorylation of AMPK by AMPKK [3] , although in this case it is not yet clear whether the effect is to oppose mechanism (2) or (4), or both. Multiple isoforms of AMPK have been identified These multiple inputs of AMP mean that, above a certain threshold concentration, a small rise in AMP will produce a large activation of the downstream kinase. The effect of AMP will also be antagonized by high concentrations of ATP. In the intact cell, ATP and AMP vary in a reciprocal manner, due to the action of adenylate kinase, which maintains the reaction 2ADPct ATP+AMP close to equilibrium (I&% 1). In normal, fully energized cells, the ATP:ADP ratio is maintained at a high level by oxidative phosphorylation, and adenylate kinase then keeps AMP concentrations very low. However, if the cell experiences some stress that interferes with ATP production and lowers the ATP:ADP ratio, the adenylate kinase equilibrium is displaced to the right and the AMP:ATP ratio rises (approximately as the square of the ADP:ATP ratio), thus activating the AMPK system [7] .
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One of the original [8] and now well estab- lished targets for AMPK is acetyl-CoA carboxylase (ACC), which catalyses a key regulatory step in fatty acid synthesis. AMPK phosphorylates ACC at three sites (Ser-79, Ser-1200 and Ser-1215), and all of these sites are phosphorylated in intact cells and in vivo [9, 10] . Phosphorylation at Ser-79 leads to a large decrease in V,,, as well as to a decrease in sensitivity to the allosteric activator, citrate [11, 12] . It has now been shown that several stresses that deplete ATP and activate AMPK lead to inactivation of ACC and marked inhibition of fatty acid synthesis in isolated rat hepatocytes. These treatments include high fructose concentrations in the medium [13] , and heat shock and arsenite (a tricarboxylic acid cycle inhibitor) [14] . Similar effects are observed on incubation of cells with 5-aminoimidazole-4-carboxamide (AICA) riboside, which is taken up by cells and converted into the AMP analogue AICA riboside monophosphate, causing AMPK activation without affecting intracellular levels of AMP, ADP or ATP [15] . The product of ACC, malonyl-CoA, is a potent inhibitor of fatty acid oxidation, due to its ability to inhibit fatty acid uptake into mitochondria via inhibition of carnitine palmitoyltransferase I [16] . It is now becoming clear that inhibition of ACC by AMPK can have the dual purpose of conserving ATP by inhibiting fatty acid synthesis, and promoting ATP production by stimulating fatty acid oxidation (see for example, [17] ). Skeletal and cardiac muscles express a novel, higher-molecular-mass isoform of ACC (ACC280, probably corresponding to the product of the ACC-P gene [18] , otherwise known as ACC-2 [19] ), but do not carry out fatty acid synthesis. Muscle tissues also express a novel isoform of carnitine palmitoyltransferase I that is much more sensitive to inhibition by malonylCoA [20] . In these tissues, regulation of fatty acid oxidation now appears to be one of the primary functions of AMPK. ACC purified from rat muscle (predominantly ACC280) is phosphorylated and inactivated by AMPK in v i m [21] . In rat skeletal muscle in vivo, prolonged exercise leads to activation of AMPK, inhibition of ACC, and depression of malonyl-CoA [22] . In electrically stimulated muscle, the activation of AMPK is associated with concomitant increases
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in AMP and decreases in ATP [23] . Interestingly, it has recently been reported that the activation of AMPK in response to electrical stimulation is restricted to the a2 isoform [24] . In perfused rat heart, ischaemia caused by ligation of coronary arteries is associated with rapid activation of AMPK, inhibition of ACC, and decreases in malonyl-CoA. Malonyl-CoA remains depressed during subsequent reperfusion, and this may explain the very high rates of fatty acid oxidation which then occur [25, 26] .
The other 'classical' [27] [3 11 . This work has confirmed, using a protein substrate, the recognition motif for AMPK previously proposed from synthetic peptide substrates. Perhaps more interestingly, we also constructed three mutants (all functional as HMGRs) that were phosphorylated more rapidly than the wild type, in one case five times more rapidly. We are currently examining the effects of stable expression of HMGR carrying these mutations in UT-2 cells. Our results suggest that, unlike ACC, which has almost the 'optimal' AMPK recognition motif, HMGR has not been selected to be an optimal substrate for AMPK. This is consistent with our findings that fatty acid synthesis is markedly inhibited by a mild heat stress (42°C) in isolated hepatocytes, but that sterol synthesis is only inhibited by more severe conditions (45 "C) [ 141. It seems possible that fatty acid synthesis may be dispensable under acute stress conditions (at least in the short term), but that cells may prefer to maintain at least a low rate of isoprenoid/sterol synthesis. A third target for AMPK, which is now well established as a physiological target for AMPK, is hormone-sensitive lipase, which catalyses the hydrolysis of triacylglycerols in adipocytes, and of cholesterol esters in many cell types [32] . AMPK phosphorylates rat hormone-sensitive lipase at Ser-565, and this prevents phosphorylation at Ser-563 and consequent activation of the enzyme by CAMP-dependent protein kinase [33] . As expected from these in vitro results, activation of AMPK by AICA riboside in isolated adipocytes antagonizes the activation of lipolysis by CAMPelevating agents [15, 34] . We have argued [2] that this represents a mechanism for ensuring that recycling of free fatty acids into triacylglycerols or cholesterol esters (which consumes ATP) does not occur when ATP is depleted.
Although all of these well established substrates for AMPK are involved in regulation of lipid metabolism, the kinase phosphorylates other targets in vitro, including glycogen synthase [35] (catalysing the key regulatory step of glycogen synthesis) and the protein kinase Raf-1 [36] (involved in signal transduction from protein-tyrosine kinase receptors to the mitogenactivated protein kinase pathway). Although further work is required to prove that these are physiological targets, we believe that it will turn out that the role of AMPK is not restricted to lipid metabolism. Its original discovery because of its ability to inhibit enzymes of lipid biosynthesis may merely reflect the fact that these are 'luxury' pathways that are dispensable in the short term in the event that the energy status of the cell is compromised. Studies in this laboratory were supported by the Wellcome Trust and the Medical Research Council.
